Verruciform xanthoma

From WikiMD's WELLNESSPEDIA


Verruciform xanthoma
Synonyms
Pronounce N/A
Specialty N/A
Symptoms Papule or nodule with a verrucous surface
Complications
Onset
Duration
Types
Causes Unknown
Risks
Diagnosis Biopsy and histopathology
Differential diagnosis Squamous cell carcinoma, Verruca vulgaris, Condyloma acuminatum
Prevention
Treatment Surgical excision
Medication
Prognosis Excellent
Frequency Rare
Deaths


Verruciform xanthoma is a rare and benign condition that affects the oral mucosa. It is characterized by the presence of papillomatous, verrucous, or flat lesions, which are usually asymptomatic. The condition was first described by Shafer in 1971.

Etiology[edit]

The exact cause of verruciform xanthoma is unknown. However, it is believed to be associated with chronic inflammation or trauma. It has also been reported in association with certain conditions such as lichen planus, discoid lupus erythematosus, and Darier's disease.

Clinical Features[edit]

Verruciform xanthoma typically presents as a solitary lesion, although multiple lesions have been reported. The lesions are usually asymptomatic and can vary in size from a few millimeters to several centimeters. They are most commonly found on the oral mucosa, particularly the gingiva, hard palate, and tongue.

Histopathology[edit]

Histologically, verruciform xanthoma is characterized by the presence of parakeratosis, acanthosis, and elongation of the rete ridges. The most distinctive feature is the presence of large, foam cells (xanthoma cells) in the connective tissue papillae.

Diagnosis[edit]

The diagnosis of verruciform xanthoma is based on the clinical and histopathological features. Other conditions that may mimic verruciform xanthoma include squamous cell carcinoma, verrucous carcinoma, and condyloma acuminatum. Therefore, a biopsy is essential for accurate diagnosis.

Treatment[edit]

The treatment of choice for verruciform xanthoma is surgical excision. The prognosis is excellent, with a low recurrence rate.

See Also[edit]

Stub icon

This WikiMD article can only be edited by registered and verified editors. You can log in or register.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Verruciform_xanthoma&oldid=6542187"